Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
基本信息
- 批准号:10254383
- 负责人:
- 金额:$ 24.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAttenuatedAutonomic DysfunctionAutonomic nervous systemBirthBloodBlood PressureBlood flowCardiacCardiac OutputCardiovascular systemCatecholaminesChronicClinicalDataDisadvantagedDown SyndromeExerciseGeneticHealthHeart RateImpairmentIndividualIntellectual functioning disabilityKnowledgeLower Body Negative PressureMeasuresMediatingMetabolicMotivationMuscleNatureNutrientOxygenOxygen ConsumptionPeripheralPhysical FunctionRegulationResearchResearch ProposalsRiskShunt DeviceTestingTissuesVasodilationWorkblood pressure regulationclinical practicedesigndisabilityexercise interventionexercise trainingexperienceimprovedmortalityperipheral bloodphysical inactivityresponsevasoconstriction
项目摘要
Down syndrome (DS) is the most prevalent genetic cause of intellectual disability and occurs in
approximately 1 in every 700 births in the US. Individuals with DS are at increased risk for a number of
health issues. Work capacity is an important predictor of declining health or physical function, and of
mortality, and is commonly measured as peak oxygen consumption. Peak oxygen consumption is very
low in individuals with DS, and cannot be explained by physical inactivity, lack of motivation, or lack of
understanding of the test. To date, the nature of the limitations in work capacity in DS is unknown, and the
proposed research aims to address this knowledge gap.
Work capacity is determined by central and peripheral regulation of blood flow (i.e. cardiac output and
maintaining arterial blood pressure vs. supplying exercising muscles with oxygen and nutrients). These
factors are governed by the sympathetic and parasympathetic branches of the autonomic nervous
system. Central regulation of blood flow is impaired in individuals with DS due to cardiovascular
autonomic dysfunction, whereby parasympathetic activity is high and sympathetic control is reduced. This
results in lower heart rate, less adequate blood pressure control and attenuated catecholamine levels
during exercise. It is unknown to what extent this impaired central control impacts cardiac output, and
subsequently work capacity, during exercise in individuals with DS.
Peripheral blood flow regulation is even less studied in individuals with DS. Peripheral regulation involves
sympathetically regulated vasoconstriction in non-active muscles and tissues, and local mechanisms
regulating vasodilation in working muscles, which facilitates blood flow to working muscle in order to meet
metabolic demand. Individuals with DS may partly experience reduced work capacity due to this inability
to shunt blood to the working tissue effectively.
The aim of this research proposal is therefore to determine the impact of limitations in central and
peripheral regulation of blood flow on work capacity in individuals with DS. We aim to examine the
responses to exercise training to better understand the underlying mechanisms and the potential to
improve health by using this knowledge in exercise interventions.
唐氏综合征(DS)是智力残疾的最普遍的遗传原因,
在美国,每700个新生儿中就有一个。患有DS的个体在许多方面的风险增加,
健康问题。工作能力是健康或身体功能下降的重要预测因素,
死亡率,并且通常测量为峰值耗氧量。峰值耗氧量非常
DS患者的低,并且不能解释为缺乏身体活动,缺乏动力或缺乏
理解测试。到目前为止,DS工作能力限制的性质尚不清楚,
拟议的研究旨在弥补这一知识差距。
做功能力由血流的中枢和外周调节(即心输出量和
维持动脉血压与向运动肌肉供应氧气和营养物)。这些
这些因素是由自主神经的交感神经和副交感神经分支控制的
系统由于心血管疾病,DS患者的血流中枢调节受损
自主神经功能障碍,由此副交感神经活性高并且交感神经控制降低。这
导致心率降低、血压控制不足和儿茶酚胺水平降低
在运动中。尚不清楚这种受损的中枢控制在多大程度上影响心输出量,
随后的工作能力,在个人与DS运动。
外周血流量调节在DS患者中的研究更少。外围调节包括
交感神经调节非活动性肌肉和组织的血管收缩,以及局部机制
调节工作肌肉中的血管舒张,这有助于血液流向工作肌肉,以满足
代谢需求。患有DS的个人可能会部分地由于这种能力而降低工作能力
有效地将血液分流到工作组织。
因此,本研究提案的目的是确定中央和地方限制的影响,
外周血流量调节对DS患者做功能力的影响。我们的目的是研究
对运动训练的反应,以更好地了解潜在的机制和潜力,
通过在运动干预中使用这些知识来改善健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thessa Hilgenkamp其他文献
Thessa Hilgenkamp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thessa Hilgenkamp', 18)}}的其他基金
Predictors of mortality and of healthy survival in a large community-based prospective cohort of aging adults with Down syndrome
大型社区前瞻性唐氏综合症老年人队列中死亡率和健康生存的预测因子
- 批准号:
10703503 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别:
Predictors of mortality and of healthy survival in a large community-based prospective cohort of aging adults with Down syndrome
大型社区前瞻性唐氏综合症老年人队列中死亡率和健康生存的预测因子
- 批准号:
10515414 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别:
Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
- 批准号:
10020792 - 财政年份:2019
- 资助金额:
$ 24.38万 - 项目类别:
Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
- 批准号:
10018130 - 财政年份:2019
- 资助金额:
$ 24.38万 - 项目类别:
Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
- 批准号:
9371097 - 财政年份:2017
- 资助金额:
$ 24.38万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 24.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 24.38万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别:
Idea to Innovation